Companies › RNAC

CARTESIAN THERAPEUTICS INC (RNAC)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001453687 · EDGAR filings · Updated 2026-07-22

CARTESIAN THERAPEUTICS INC (RNAC) has reported institutional ownership of 24.3%, with 83 institutional managers holding positions valued at $43.9M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-22 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-17 — Current report (8-K) filed
• 2026-06-09 — Notice of proposed sale filed (Form 144)
• 2026-06-09 — Current report (8-K) filed
• 2026-06-02 — Notice of proposed sale filed (Form 144)
• 2026-05-26 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CARTESIAN THERAPEUTICS INC has 83 institutional holders and institutional ownership of 24.3%.

Insider activity

Insiders reported 33 transactions (11 buys, 3 sells) across 13 reporting insiders, with a net reported value of $1.47M.

Data flags from SEC filings

Related companies

MAXCYTE INC (MXCT) · PMV PHARMACEUTICALS INC (PMVP) · Oramed Pharmaceuticals Inc (ORMP) · ATYR PHARMA INC (ATYR) · Adicet Bio Inc (ACET) · SATELLOS BIOSCIENCE INC (MSLE)